Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
Source abstract
Abstract
Lymph‐Directed Drug Delivery In article number 2101935, Jihoon Kim, Won Jong Kim, and co‐workers introduce an albumin‐conjugated self‐immolative nitric oxide (NO) prodrug to achieve lymph‐directed NO delivery for inhibition of tumor metastasis. This novel prodrug can contribute to the on‐demand delivery of NO for biomedical applications. [Image: see text]
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.